BioPoly was granted an additional international patent for its partial resurfacing implants, which protects the unique implant designs. This builds on U.S. and international patents that address the company’s BioPoly® material, which behaves like synthetic cartilage.
Rather than replacing the entire joint, novel BioPoly resurfacing implants are designed to replace only the damaged cartilage of a patient’s joint. The implant material is a proprietary combination of hyaluronic acid and ultra-high molecular weight polyethylene, creating a self-lubricating polymer with enhanced wear properties.
The current BioPoly product offering comprises the RS Knee (shown above), RS Trochlea, RS Patella and RS Shoulder implants. The implants are approved under the CE Mark and available throughout Europe and in parts of Southeast Asia.
BioPoly was granted an additional international patent for its partial resurfacing implants, which protects the unique implant designs. This builds on U.S. and international patents that address the company’s BioPoly® material, which behaves like synthetic cartilage.
BioPoly was granted an additional international patent for its partial resurfacing implants, which protects the unique implant designs. This builds on U.S. and international patents that address the company’s BioPoly® material, which behaves like synthetic cartilage.
Rather than replacing the entire joint, novel BioPoly resurfacing implants are designed to replace only the damaged cartilage of a patient’s joint. The implant material is a proprietary combination of hyaluronic acid and ultra-high molecular weight polyethylene, creating a self-lubricating polymer with enhanced wear properties.
The current BioPoly product offering comprises the RS Knee (shown above), RS Trochlea, RS Patella and RS Shoulder implants. The implants are approved under the CE Mark and available throughout Europe and in parts of Southeast Asia.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
